Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Antitussives Stories

2009-12-14 12:04:00

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey: "Findings released today on this year's Monitoring the Future survey speak to the need for continued efforts to educate and empower parents with the information they need to talk to their teens about medicine abuse. The...

2009-10-20 06:35:00

Calls upon U.S. Congress to Join in this Fight to Stop Medicine Abuse WASHINGTON, Oct. 20 /PRNewswire-USNewswire/ -- Dr. Drew Pinsky, a nationally renowned drug abuse expert, and the Five Moms, five exceptional women dedicated to spreading the word about the dangers of cough medicine abuse, are speaking out to educate parents and congressional staff on Capitol Hill about the issue of over-the-counter (OTC) cough medicine abuse among teens and how to prevent it through education. While...

2009-08-19 23:12:41

A doctor in Canada warns the use of codeine to treat pain following a tonsillectomy could prove fatal for some children. Dr. Gideon Koren of the University of Western Ontario investigated the death of a 2-year-old boy following a tonsillectomy. Koren said enlarged tonsils are usually treated with antibiotics, but tonsillectomies are performed in the case of sleep apnea, in which the child stops breathing while asleep. The toddler, who had a history of snoring and sleep-study-confirmed sleep...

2009-08-14 06:00:00

BIRMINGHAM, Ala., Aug. 14 /PRNewswire/ -- Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announced plans to commercially launch Clofera(TM) for the temporary relief of cough and nasal congestion. Clofera(TM) is indicated for the temporary relief of cough and nasal congestion due to the common cold, hay fever, or other upper respiratory allergies. Clofera(TM) contains a non-narcotic antitussive, chlophedianol...

1d72e2a95a1cb53b2784f0cd6684fea01
2009-07-08 06:25:00

Stronger warnings are on the way for painkillers Darvon, Darvocet, and their generic cousins. They are allowed to stay on the market for now, despite pressure from a consumer group to ban the medicine. The Food and Drug Administration's decision is very different from Britain, which banned the drugs several years ago. British lawmakers pointed out numerous suicides and accidental overdoses. European Union countries are considering a similar move. The recent U.S. changes apply to drugs made...

2009-07-07 16:56:00

NEWPORT, Ky., July 7 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. has reached an agreement with the FDA to keep propoxyphene-containing products Darvon(R) (propoxyphene hydrochloride), Darvon-N(R) (propoxyphene napsylate), Darvocet-N(R) 50 & Darvocet-N(R) 100 (propoxyphene napsylate and acetaminophen) available as treatment options for the management of mild to moderate pain. This action follows a joint committee meeting with the U.S. Food and Drug Administration (FDA) Anesthetic and...

2009-07-07 12:43:23

The U.S. Food and Drug Administration says it has ordered strengthened warnings for drugs, such as Darvon and Darvocet, that contain propoxyphene. The federal agency is requiring manufacturers of propoxyphene-containing products to strengthen the label, including the boxed warning, emphasizing the potential for overdose. The manufacturers will also be required to provide a medication guide to patients stressing the importance of using the drugs as directed. In addition, the FDA ordered a new...

0769da71291244154db0e6c0d4e8c5981
2009-06-26 05:41:59

A European watchdog group is calling for a painkiller that has been used for over 40 years to be taken off shelves, insisting that its risks are greater then its benefits. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) said on Thursday that medicine that has dextropropoxyphene is not more successful than other, safer painkillers. The Committee stated in a press release that it was advising that these medicines be removed from stores across the European...

2009-06-18 07:00:00

LAIYANG, China, June 18 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: JGBO) (the "Company", "Jiangbo"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it will attend the China New Drugs Trade Fair from June 26 to 28, 2009 at Tianjin Binhai International Convention & Exhibition Center, and also plans to launch a new promotional campaign for its recently acquired Laiyang...

1f1de599b43dbe3ff40fd7925219281b1
2009-01-30 15:45:00

On Friday, federal health officials got together for a public hearing on whether to ban Darvon, a painkiller first approved in 1957. The drug, now known as Darvocet, includes a dose of acetaminophen and remains one of the top 25 most commonly prescribed medications. Over 20 million prescriptions were written in 2007. Public Citizen, a consumer group, said the FDA should withdraw Darvon from the market because the drug offers relatively weak pain relief and poses an overdose risk, with...